BioCatalyst

QLS-111 Ophthalmic Solution (0.015%), QLS-111 Ophthalmic Solution (0.075%) — catalyst calendar

1 verified catalyst event(s) referencing QLS-111 Ophthalmic Solution (0.015%), QLS-111 Ophthalmic Solution (0.075%), each linked to its official source. Verified as of 2026-08-06.

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-09 (month)
in 26d
ESTIMATED
 READOUT
Single-site Pilot Study Evaluating the Effect of QLS-111 Ophthalmic Solution on
Phase 2 · Non-proliferative Diabetic Retinopathy (NPDR), Open-angle Glaucoma (OAG)
 Qlaris Bio, Inc. QLS-111 Ophthalmic Solution (0.015%), QL ClinicalTrials.gov ↗
✓ Source-checked 2026-08-06
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.